What is the appropriate ondansetron (Zofran) dose for a 9‑year‑old child?

Ondansetron Dosing for a 9-Year-Old Child

For a 9-year-old child, administer ondansetron at 0.15 mg/kg per dose (maximum 16 mg per single dose), with the exact dose depending on the child's weight. 1

Weight-Based Calculation

A typical 9-year-old weighs approximately 25-40 kg, which translates to the following doses using the standard 0.15 mg/kg calculation: 1

• 25 kg child: 3.75 mg per dose
• 30 kg child: 4.5 mg per dose
• 35 kg child: 5.25 mg per dose
• 40 kg child: 6 mg per dose

Calculate the dose precisely according to the child's actual weight—avoid rounding beyond the exact 0.15 mg/kg calculation to prevent under- or overdosing. 1

Route and Frequency by Clinical Context

For Acute Gastroenteritis/Vomiting

• Oral administration: Give a single dose of 0.15 mg/kg (maximum 8 mg for oral dosing in some protocols, though 16 mg is the absolute ceiling). 1, 2
• Ondansetron can be given without regard to meals, though co-administration with food may improve gastrointestinal tolerability. 1
• A single oral dose has been shown to reduce recurrent vomiting, need for IV fluids, and hospital admissions in children with acute gastroenteritis. 2

For Chemotherapy-Induced Nausea/Vomiting

• Administer 0.15 mg/kg IV or IM (maximum 16 mg) 30 minutes before chemotherapy, then repeat at 4 and 8 hours after the first dose for highly emetogenic chemotherapy. 1
• Combining ondansetron with dexamethasone significantly improves efficacy for children receiving highly emetogenic chemotherapy. 1, 3
• For moderate-emetic-risk chemotherapy, ondansetron combined with dexamethasone is the recommended two-drug regimen. 1

For Postoperative Nausea/Vomiting

• Intravenous ondansetron 0.1-0.15 mg/kg is effective for preventing postoperative emesis in children undergoing procedures with high PONV risk (e.g., tonsillectomy, strabismus repair). 3
• Ondansetron combined with dexamethasone or propofol-based anesthesia is more effective than ondansetron alone. 3

Critical Safety Considerations

QT Interval Prolongation

• Ondansetron can prolong the QT interval in a dose-dependent manner; the pediatric dose of 0.15 mg/kg with a 16 mg maximum provides an appropriate safety margin. 1
• Avoid ondansetron in children with congenital long QT syndrome or electrolyte abnormalities (hypokalemia, hypomagnesemia). 1

Age Restrictions

• Ondansetron should only be used in children ≥6 months of age due to limited safety and efficacy data in younger infants. 1, 4

Overdose Risk

• Despite ondansetron's excellent safety profile at therapeutic doses, severe toxicity including seizures, obtundation, and serotonin syndrome has been reported in infants following overdose. 5
• Parents should be counseled on proper storage to prevent accidental ingestion by younger siblings. 5

Common Pitfalls to Avoid

• Do not exceed 16 mg per single dose, even in heavier children, as higher doses increase the risk of QT prolongation without additional antiemetic benefit. 1
• Do not use the adult 8 mg three-times-daily regimen for moderately emetogenic chemotherapy in children—weight-based dosing is more appropriate. 6
• Recognize that ondansetron is more effective for acute vomiting than delayed symptoms; for delayed chemotherapy-induced nausea, consider adding dexamethasone or using alternative agents like palonosetron. 1, 3

Comparative Efficacy

• Ondansetron is superior to metoclopramide, domperidone, bromopride, and droperidol for preventing vomiting in children, with fewer side effects (particularly less somnolence and extrapyramidal symptoms). 3, 7, 8
• At 24 hours post-treatment, ondansetron maintained efficacy in 96.6% of children with acute gastroenteritis, compared to 67-68% with bromopride or metoclopramide. 8